Dianthus Therapeutics Q4 EPS $(1.43) Misses $(1.02) Estimate, Sales $284.000K Miss $398.917K Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings MissesNews
Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(1.43) per share which missed the analyst consensus estimate of $(1.02) by 39.51 percent. This is a 76.54 percent decrease over losses of $(0.81) per
Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(1.43) per share which missed the analyst consensus estimate of $(1.02) by 39.51 percent. This is a 76.54 percent decrease over losses of $(0.81) per share from the same period last year. The company reported quarterly sales of $284.000 thousand which missed the analyst consensus estimate of $398.917 thousand by 28.81 percent. This is a 78.57 percent decrease over sales of $1.325 million the same period last year.